During the past decade, Le Mans University Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Le Mans University Hospital" are "Hemophilia" (1 trials), "Intravenous Injections" (1 trials), "Pain Management" (1 trials) and "Vaccination" (1 trials). Many other conditions were trialed in "Le Mans University Hospital" in a lesser frequency.

Most popular intervention types in "Le Mans University Hospital" are "Drug" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Buzzy® device" (1 trials), "EMLAPATCH (lidocaine, prilocaine)" (1 trials), "Ketamine" (1 trials), "Morphine" (1 trials) and "No Interventional study" (1 trials). Other intervention names were less common.

The vast majority of trials in "Le Mans University Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Le Mans University Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Le Mans University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Le Mans University Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".